In this E-Book we discuss:
More about this E-Book
Cutting-edge technologies are leading to the development of increasing numbers of novel CAR-T and cell therapies, necessitating the development of more efficient and accurate methods for evaluating the quality of this influx of CAR-T therapy candidates.
IsoPlexis does this on an integrated, walk-away automated platform for single-cell and bulk functional proteomics, providing easy access to highly multiplexed proteomics for virtually any lab.
Download this eBook to explore case studies and learn more!